Weekly Highlight of Top Insider Buys: Chevron Corp., Gilead Sciences Inc., Dell Inc., Sara Lee Corp., and Vertex Pharmaceuticals Inc.

Weekly Highlight of Top Insider Buys: CVX, GILD, DELL, SLE, VRTX

Author's Avatar
May 09, 2010
Weekly highlight of top insider buys: Chevron Corp. (CVX, Financial), Gilead Sciences Inc. (GILD, Financial), Dell Inc. (DELL, Financial), Sara Lee Corp. (SLE, Financial), and Vertex Pharmaceuticals Inc. (VRTX, Financial).


Executive Vice President of Chevron Corp., Michael K Wirth, bought 11,400 shares on 5/06/10 at an average price of $77.1.

Chevron is the fifth-largest integrated energy company in the world. Chevron Corp. has a market cap of $154.84 billion; its shares were traded at around $77.1 with a P/E ratio of 11.9 and P/S ratio of 1. The dividend yield of Chevron Corp. stocks is 3.5%. Chevron Corp. had an annual average earning growth of 11.5% over the past 10 years. GuruFocus rated Chevron Corp. the business predictability rank of 3-star.



On April 30, Chevron Corporation reported earnings of $4.55 billion ($2.27 per share - diluted) for the first quarter 2010, compared with $1.84 billion ($0.92 per share – diluted) in the 2009 first quarter. Results in the 2009 period included gains of approximately $400 million ($0.20 per share) from downstream asset sales. Foreign-currency effects reduced earnings in the 2010 quarter by $198 million, compared with a reduction of $54 million a year earlier.



Chevron Corp. is in the portfolios of thirteen Gurus: John Hussman, Charles Brandes, NWQ Managers, George Soros, Ruane Cunniff, Kenneth Fisher, Irving Kahn, Brian Rogers, Richard Aster Jr, David Dreman, Dodge & Cox, and Richard Snow..



Last week, Buy:: Executive Vice President Michael K Wirth bought 11,400 shares of CVX stock. Sell:: Executive Vice President Michael K Wirth and Sell:: Director Robert J Eaton sold shares in November.



Gilead Sciences Inc. (GILD): Director Olsen Per Wold Bought 12,800 Shares

Director of Gilead Sciences Inc., Olsen Per Wold, bought 12,800 shares on 5/04/10 at an average price of $38.37.

Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. Gilead Sciences Inc. has a market cap of $34.61 billion; its shares were traded at around $38.37 with a P/E ratio of 11.8 and P/S ratio of 4.9.

On Apr 20, Gilead Sciences, Inc. announced its results of operations for the quarter ended March 31, 2010. Total revenues for the first quarter of 2010 were $2.09 billion, up 36 percent compared to total revenues of $1.53 billion for the first quarter of 2009. Net income for the first quarter of 2010 was $854.9 million, or $0.92 per diluted share, compared to net income for the first quarter of 2009 of $589.1 million, or $0.63 per diluted share. Non-GAAP net income for the first quarter of 2010, which excludes after-tax acquisition-related expenses, restructuring expenses and stock-based compensation expenses, was $914.8 million, or $0.99 per diluted share. Non-GAAP net income for the first quarter of 2009, which excludes after-tax stock-based compensation expenses, was $619.4 million, or $0.66 per diluted share.



Gilead Sciences Inc. is owned by George Soros, lee Ainslie, and Edward Owens.



Last week, Buy:: Director Olsen Per Wold bought shares of GILD stock and Sell:: EVP, Corp & Med Affairs Gregg H Alton sold shares. Sell:: Chairman and CEO John C Martin sold 100,000 shares last month and Sell:: EVP, R&D and CSO Norbert W Bischofberger sold 53,754 shares in February.



Dell Inc. (DELL): Director James Breyer Bought 20,000 Shares

Director of Dell Inc., James Breyer, bought 20,000 shares on 5/05/10 at an average price of $15.01.

Dell Inc. is a premier provider of products and services required for customers worldwide to build their information-technology and Internet infrastructures. Dell Inc. has a market cap of $29.39 billion; its shares were traded at around $15.01 with a P/E ratio of 15.1 and P/S ratio of 0.6. Dell Inc. had an annual average earning growth of 4.1% over the past 10 years.



On February 18, Dell Inc. reported results for the fourth quarter. Total revenue in the quarter ended Jan. 29 was $14.9 billion, an 11-percent increase from a year ago and a 16-percent sequential gain. Revenue improved in all of Dell’s business segments as the company consolidated results from the former Perot Systems for the first time. Cash flow from operations was $1.3 billion for the quarter, $3.9 billion for the full fiscal year. Dell ended the quarter in which it completed the acquisition of Perot Systems with $11.8 billion in cash and investments.



Dell Inc. is in the portfolios of seventeen Gurus: John Hussman, John Rogers, Jean-Marie Eveillard, Wallace Weitz, Robert Olstein, PRIMECAP Management, Mason Hawkins, Prem Watsa, Bill Nygren, Brian Rogers, Donald Yactkman, Arnold Schneider, Richard Pzena, Arnold Van Den Berg, Charles Brandes, Glenn Greenberg, and George Soros.

Last week, Buy:: Director James Breyer bought 20,000 shares of DELL stock. In March, Sell:: CAO Thomas W Sweet, Sell:: President Ronald Garriques, and Sell:: Chief Marketing Officer Erin C Nelson sold shares.



Sara Lee Corp. (SLE): EVP, CFO Marcel H.m. Smits Bought 15,000 Shares

EVP, CFO of Sara Lee Corp., Marcel H.M. Smits, bought 15,000 shares on 5/07/10 at an average price of $13.44.

Sara Lee Corporation is a global manufacturer and marketer of high-quality, brand-name products for consumers throughout the world. Sara Lee Corp. has a market cap of $8.88 billion; its shares were traded at around $13.44 with a P/E ratio of 11 and P/S ratio of 0.7. The dividend yield of Sara Lee Corp. stocks is 3.2%.



On May 6, Sara Lee Corp. reported results for the third quarter of fiscal 2010. Net sales for the third quarter of fiscal 2010 were $2.6 billion, unchanged versus the year-ago period as favorable

Sara Lee Corp. is owned by six Gurus: Donald Yactkman, Jean-Marie Eveillard, George Soros, David Dreman, Charles Brandes, and Richard Pzena. . 2 Gurus Initiated Positions in

Last week, Buy:: Chair & CEO Brenda C Barnes and Buy:: EVP, CFO Marcel H.m. Smits bought shares of SLE stock.



Vertex Pharmaceuticals Inc. (VRTX): Director Jeffrey M Leiden Bought 1,300 Shares

Director of Vertex Pharmaceuticals Inc., Jeffrey M Leiden, bought 1,300 shares on 5/04/10 at an average price of $35.9.

Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. Vertex Pharmaceuticals Inc. has a market cap of $7.2 billion; its shares were traded at around $35.9 with and P/S ratio of 70.5. Vertex Pharmaceuticals Inc. had an annual average earning growth of 16.6% over the past 10 years.

On April 21, Vertex Pharmaceuticals Inc. reported results for the first quarter of 2010. For the quarter ended March 31, 2010, the Company's GAAP net loss was $165.3 million, or $0.83 per share, including certain charges totaling $25.2 million, compared to a GAAP net loss for the quarter ended March 31, 2009 of $162.7 million, or $1.04 per share, including certain charges totaling $34.0 million. The non-GAAP loss, before certain charges, for the quarter ended March 31, 2010 was $140.1 million, or $0.70 per share, compared to $128.7 million, or $0.83 per share, for the quarter ended March 31, 2009. The increase in the Company's 2010 non-GAAP loss was principally attributable to increased costs to support advancement of telaprevir toward potential launch. Total revenues for the quarter ended March 31, 2010 were $22.4 million, compared to $24.0 million for the first quarter of 2009.



Vertex Pharmaceuticals Inc. is in the portfolio of Edward Owens.



Last week, Buy:: Director Jeffrey M Leiden bought 1,300 shares of VRTX stock. Buy:: Director Jeffrey M Leiden bought 1,300 shares last month; Buy:: Director Dennis L Winger bought 6,500 shares in February. Last month, Sell:: EVP, Global R&D, CSO Peter Mueller and Sell:: EVP & CFO Ian F Smith sold shares. color=red]Sell:[/color]: Director Roger W Brimblecombe sold shares in March.

For the complete list of stocks that bought by their company executives, go to: Insider Buys.